Cite
HARVARD Citation
Fordham, N. et al. (2021). First reported case of safe and efficacious use of tocilizumab for treatment of hyperinflammatory syndrome associated with COVID‐19 in an allogeneic stem cell transplant patient. EJHaem. 2 (1), pp. 143-146. [Online].